Muhamad N - Search Results

1

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.

Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Muhamad N, et al. Int J Nanomedicine. 2018 Jul 4;13:3921-3935. doi: 10.2147/IJN.S165210. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30013345 Free PMC article. Review.

2

Metabolite Profiling in Anticancer Drug Development: A Systematic Review.

Muhamad N, Na-Bangchang K. Muhamad N, et al. Drug Des Devel Ther. 2020 Apr 9;14:1401-1444. doi: 10.2147/DDDT.S221518. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32308372 Free PMC article.

3

Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea.

Na-Bangchang K, Kulma I, Plengsuriyakarn T, Tharavanij T, Kotawng K, Chemung A, Muhamad N, Karbwang J. Na-Bangchang K, et al. Among authors: muhamad n. J Tradit Complement Med. 2021 Feb 4;11(4):343-355. doi: 10.1016/j.jtcme.2021.02.002. eCollection 2021 Jul. J Tradit Complement Med. 2021. PMID: 34195029 Free PMC article.

4

Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice.

Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Muhamad N, et al. PLoS One. 2022 Nov 14;17(11):e0277614. doi: 10.1371/journal.pone.0277614. eCollection 2022. PLoS One. 2022. PMID: 36374864 Free PMC article.

5

Bioassay for total serum bioactivity of Atractylodes lancea.

Na-Bangchang K, Cheoymang A, Muhamad N, Kulma I. Na-Bangchang K, et al. Among authors: muhamad n. J Adv Pharm Technol Res. 2023 Jan-Mar;14(1):51-55. doi: 10.4103/japtr.japtr_431_22. Epub 2023 Jan 20. J Adv Pharm Technol Res. 2023. PMID: 36950462 Free PMC article.

6

The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics.

Muhamad N, Na-Bangchang K. Muhamad N, et al. Pharmacol Res Perspect. 2023 Dec;11(6):e01149. doi: 10.1002/prp2.1149. Pharmacol Res Perspect. 2023. PMID: 37902256 Free PMC article.

7

MyACR: A Point-of-Care Medical Device for Determination of Albumin-Creatinine Ratio (uACR) in Random Urine Samples as a Marker of Nephropathy.

Muhamad N, Youngvises N, Plengsuriyakarn T, Meesiri W, Chaijaroenkul W, Na-Bangchang K. Muhamad N, et al. Diagnostics (Basel). 2024 Aug 6;14(16):1702. doi: 10.3390/diagnostics14161702. Diagnostics (Basel). 2024. PMID: 39202190 Free PMC article.

8

The pharmacokinetic differences between 10- and 15-μg daily vitamin D doses.

You T, Muhamad N, Jenner J, Huang Z. You T, et al. Among authors: muhamad n. Br J Clin Pharmacol. 2024 Oct;90(10):2611-2620. doi: 10.1111/bcp.16146. Epub 2024 Jun 26. Br J Clin Pharmacol. 2024. PMID: 38926090

9

Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC class II deficiency.

Muhamad NDA, Kanie N, Otsubo Y, Suzuki K, Kinoshita K, Horikoshi Y. Muhamad NDA, et al. J Infect Chemother. 2025 Jan 23;31(4):102627. doi: 10.1016/j.jiac.2025.102627. Online ahead of print. J Infect Chemother. 2025. PMID: 39863069

10

Influence of SS316L Nanoparticles on the Sintered Properties of Two-Component Micro-Powder Injection Moulded Bimodal SS316L/Zirconia Bi-Materials.

Basir A, Sulong AB, Muhamad N, Juri AZ, Jamadon NH, Foudzi FM, Radzuan NAM, Rashidi K. Basir A, et al. Among authors: muhamad n. Materials (Basel). 2024 Nov 13;17(22):5536. doi: 10.3390/ma17225536. Materials (Basel). 2024. PMID: 39597359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters